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Abstract: Selenium has signifi cant health benefi ts, including potent cancer 
prevention activity and roles in immune function and the male reproductive 
system. Selenium-containing proteins, which incorporate this essential micro-
nutrient as selenocysteine, are proposed to mediate the positive effects of di-
etary selenium. Presented here are the solution NMR structures of the seleno-
protein SelM and an ortholog of the selenoprotein Sep15. These data reveal 
that Sep15 and SelM are structural homologs that establish a new thioredoxin-
like protein family. The location of the active-site redox motifs within the fold 
together with the observed localized conformational changes after thiol-disul-
fi de exchange and measured redox potential indicate that they have redox ac-
tivity. In mammals, Sep15 expression is regulated by dietary selenium, and 
either decreased or increased expression of this selenoprotein alters redox ho-
meostasis. A physiological role for Sep15 and SelM as thiol-disulfi de oxido-
reductases and their contribution to the quality control pathways of the endo-
plasmic reticulum are discussed. 
Abbreviations: NOESY two-dimensional nuclear Overhauser (NOE) effect 
spectroscopy; HSQC, heteronuclear single quantum correlation; Bis-Tris, 2-
[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol; siRNA, small 
interfering RNA; UGGT, UDP-glucose:glycoprotein glucosyltransferase.
Introduction 
 The formation of disulfi de bonds is an essential step in the struc-
tural maturation of secretory and membrane proteins. All living or-
ganisms have evolved mechanistically related pathways to catalyze 
the formation of disulfi de bonds (1). In eukaryotes, disulfi de bonds 
are formed primarily within the lumen of the endoplasmic reticulum. 
An intricate series of protein folding and quality control mechanisms 
localized to this organelle regulate the formation of disulfi de bonds 
through thiol-disulfi de exchange (2). 
Thiol-disulfi de oxidoreductases catalyze thiol-disulfi de exchange 
between proteins with free thiols and thiol-containing small molecules 
or proteins with disulfi de bonds. The activities of these enzymes are de-
pendent upon active-site cysteine residues that are arranged in a CXXC 
motif or CXXC-derived motifs, in which one of these cysteines may be 
replaced by selenocysteine, serine, or threonine (3). Enzymatic activity 
and the direction of exchange (oxidation or reduction) depend upon re-
dox potential, interactions with other redox proteins, and the availabil-
ity of terminal electron donors and acceptors (4). 
Selenium is an essential trace element that is incorporated into 
proteins as the 21st natural amino acid in the genetic code, seleno-
cysteine. Selenoproteins are found throughout prokaryotic (5) and 
eukaryotic proteomes (6), and most have orthologs in which seleno-
cysteine is replaced with cysteine. The identity of the active-site re-
dox motif residues (selenocysteine or cysteine) regulates the redox 
potential and catalytic effi ciency of these enzymes (7, 8). Recent 
studies provide strong evidence that dietary selenium plays an impor-
tant role in cancer prevention (9–11), immune function (12), aging 
(13), and the male reproductive system (12, 14). Although selenopro-
teins appear to mediate these effects, physiological roles for most of 
these proteins are unknown. Two recently identifi ed eukaryotic sele-
noproteins, Sep15 (15) and SelM (16), have selenocysteine-contain-
ing CXXC-like motifs, suggesting that they might function as redox 
proteins within the endoplasmic reticulum. Irrespective of this motif, 
these selenoproteins share no sequence similarities with known redox 
proteins. In an attempt to understand the physiological roles of these 
proteins, the solution NMR structures of fruit fl y Sep15 and mouse 
SelM were determined. These structures identify a thioredoxin-like 
domain and the location of the active-site redox motif. Additional 
data demonstrate that these proteins undergo localized conforma-
tional changes centered on the active-site redox motif after thiol-di-
sulfi de exchange and suggest that they function as thiol-disulfi de oxi-
doreductases that participate in the formation of disulfi de bonds. 
Materials And Methods 
Protein Expression and Purifi cation—Because recombinant sele-
noproteins are diffi cult to prepare in heterologous expression sys-
tems, the single selenocysteine residue (U48) in SelM from Mus 
musculus was mutated to cysteine (48U→C) to facilitate these struc-
tural studies. In contrast, Sep15 from D. melanogaster does not con-
tain a selenocysteine residue and, accordingly, is a natural cyste-
ine-containing ortholog of Sep15. The coding regions of the mouse 
SelM gene and the fruit fl y Sep15 gene were PCR-amplifi ed from a 
cDNA clone and a cDNA library (Novagen) with the following prim-
ers: 5’-TCCAGCCACCCATATGACCAACTACCGACCGGATTG-
GAACC-3’ and 5’-GGTGGTGGTGCTCGAGGTCGTCGTGTTCT-
GAAGCTTCCTC-3’ (residues 25-145 of SelM-48U→C including an 
uncleaved C-terminal hexahistidine tag (designated as SelM)) (16); 
5’-AAGGGCTAGCCACCATCACCATCACCATTTGGATCAG-
CAGCCG-3’ and 5’-AAGGCTCGAGTTAGATCCTGTTGGT-3’ 
(residues 62-178 of Sep15 including an uncleaved N-terminal hexa-
histidine tag (designated as Sep15)). PCR products were digested 
with NdeI/XhoI (SelM) or NheI/XhoI (Sep15), ligated into pET21a 
(SelM) or pET19b (Sep15), and verifi ed by DNA sequencing. 
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SelM and Sep15 were expressed in Escherichia coli BL21(DE3) 
cells. Cell cultures were grown at 37 °C until the A600
 reached 0.6. 
Protein expression was induced by adding 0.4 mM isopropyl-β-D-
thiogalacto-side, and the cells were grown for 16 h at 30 °C. After in-
duction, bacterial cells were harvested by centrifugation at 4700 × g 
for 15 min at 4 °C, and cell pellets were re-suspended in lysis buffer 
(50 mM Tris (pH 8.0), 150 mM NaCl, 0.1% Triton X-100, 10 mg/li-
ter lysozyme, 5 mg/liter DNase I, and EDTA-free Complete Protease 
Inhibitor Tablets (Roche Applied Science)) and lysed by sonication. 
Cell lysates were centrifuged at 40,000 × g for 30 min at 4 °C. Both 
proteins were purifi ed by immobilized metal-chelate affi nity, ion ex-
change, and gel fi ltration chromatography. 
NMR Spectroscopy—Proteins uniformly labeled with 15N or 
13C,15N were produced by supplementing M9 media with 1 g/li-
ter [15N]ammonium chloride, 3 g/liter D-[13C]glucose, 0.5 ml/liter 
0.5% thiamine, 2 mM MgSO4, 0.1 mM CaCl2, 0.5 ml/liter 10 mg/ml
 
biotin, and 100 μg/ml carbenicillin. All NMR experiments were ac-
quired at 25 °C with Varian INOVA spectrometers operating at pro-
ton frequencies of 500 and 600 MHz using 1 mM protein samples 
dissolved in 50 mM sodium phosphate (pH 6.0) and 50 mM NaCl. 
NMR data were processed with NMRPipe (17) and analyzed with 
NMRView (18). Backbone and aliphatic side chain chemical shift 
assignments were obtained from standard triple resonance experi-
ments: HNCO, HNCACB, CBCA(CO)NH, HNHA, C(CO)NH-two-
dimensional total correlation spectroscopy (TOCSY), H(CCO)NH-
TOCSY, and HCCH-TOCSY. Aromatic side chain chemical shifts 
were assigned with two-dimensional double quantum fi ltered corre-
lation spectroscopy and NOESY3 (τm = 100 ms) experiments using 
15N-labeled protein samples in 99.9% D2O. Stereospecifi c chemi-
cal shift assignments for valine and leucine methyl groups were ob-
tained with two constant time 1H, 13C HSQC experiments (28- and 
43-ms delay) using 10% 13C uniformly labeled samples (19). Re-
sidual dipolar couplings were extracted from in-phase anti-phase 
experiments using 15N-labeled samples aligned in 5% polyacryl-
amide stretched gels (20). 
Distance restraints were obtained from three-dimensional 15N-
edited NOESY (τm = 100 ms) and 
13C-edited NOESY (τm = 100 ms) 
spectra recorded from 15N- and 13C,15N-labeled proteins. Restraints 
for the dihedral backbone angles (φ,ψ) were derived from an analy-
sis of 13Cα, 13Cβ, 13CO, and 15N chemical shifts using TALOS (21). 
Error bounds for these restraints were set to twice the S.D. of the pre-
dictions with a minimum bound of ±30°. Hydrogen bond restraints 
were established for those amide protons protected from D2O ex-
change in 1H,15N HSQC experiments. 
Structure calculations were performed with ARIA (22). ARIA 
runs were initiated using a set of NOEs manually assigned from 15N-
edited NOESY spectra. NOEs from 13C-edited NOESY spectra were 
introduced into the calculation once an initial ensemble of low en-
ergy structures was obtained. MOLMOL (23) was used to assign car-
bonyl partners for amide protons that were protected from D2O ex-
change. Hydrogen bond restraints were set to 1.3 Å < dNH-O
 < 2.5 Å 
and 2.3 Å < dN-O < 3.5 Å,
 respectively. Protein alignment tensors cal-
culated with PALES (24) were used for structural refi nement against 
residual dipolar coupling data. Structural coordinates have been de-
posited in the Protein Data Bank and have been assigned the acces-
sion codes 2A2P (SelM) and 2A4H (Sep15). 
Redox Potential—Analysis of the equilibrium redox potential of 
fruit fl y Sep15 (residues 62-178) was performed as previously de-
scribed (25). Sep15, contained in 100 mM sodium phosphate (pH 
7.0), 1 mM EDTA, and various concentrations of reduced and oxi-
dized glutathione, was incubated at room temperature for 12 h. Pro-
tein samples were precipitated with cold 15% trichloroacetic acid for 
15 min, centrifuged at 15,000 × g for 10 min, washed with cold ac-
etone, and dried. Samples were re-suspended in buffer (100 mM so-
dium phosphate (pH 7.0), 1 mM EDTA and 1% SDS) and alkylated 
with 15 mM 4-acetamido-4’-maleimidylstilbene-2,2’-disulfonic acid 
(Molecular Probes) for 2 h at 37°C. Alkylated samples were resolved 
by SDS-PAGE using NuPAGE Bis-Tris gels under reducing condi-
tions followed by Western blotting using Sep15-specifi c antibodies. 
The redox potential was calculated using the Nernst equation as pre-
viously described (26). 
RNA Interference, Overexpression, and Oxidative Stress—Four 
siRNA expression cassettes (designated S1-S4) targeted against 
different regions of mouse Sep15 mRNA were generated using the 
Silencer Express Kit (Ambion) according to the manufacturer’s 
instructions. The following primers were used: S1, 5’-TGCCTA-
CACAAAGCAAGAGCTGCAGAGCAAGCGGTGTTTC-
GTCCTTTCCACAAG-3’ and 5’-CGGCGAAGCTTTTTC-
CAAAAAACTTGCTCTGCAGCTCTTGCCTACACAAAGCAA-3’; 
S2, 5’-ATCCTACACAAAGATGGCTCCTGCATACAGCCGGT-
GTTTCGTCCTTTCCACAAG-3’ and 5’-CGGCGAAGCTTTTTC-
CAAAAAAGCTGTATGCAGGAGCCATCCTACACAAAGATG-3’; 
S3, 5’-GACCTACACAAAGTCTGAGCCTCGAACATACCGGT-
GTTTCGTCCTTTCCACAAG-3’ and 5’-CGGCGAAGCTTTTTC-
CAAAAAAGTATGTTCGAGGCTCAGACCTACACAAAGTCT-3’; 
S4, 5’-AGTCTACACAAAACTTCTCGCTCAGGAACTCCGGT-
GTTTCGTCCTTTCCACAAG-3’ and 5’-CGGCGAAGCTTTTTC-
C A A A A A A G A G T T C C T G A G C G A G A A G T C TA C A -
CAAAACTT-3’. PCR products were digested with EcoRI/HindIII, 
ligated into the pSEC-hygro vector, and verifi ed by DNA sequenc-
ing. 
Mouse fi broblast NIH-3T3 cells were grown in Dulbecco’s 
modifi ed Eagle’s medium supplemented with 10% fetal calf se-
rum to ~80% confl uence. Transfections were performed using Li-
pofectamine and PLUS reagent (Invitrogen) according to the man-
ufacturer’s instructions. For each 60-mm plate, 2 μg of DNA, 8 μl 
of PLUS reagent, and 12 μl of Lipofectamine were used. Twenty-
four hours after transfection cells stably expressing Sep15-specifi c 
siRNA were isolated by resistance to hygromycin B. Down-regula-
tion of Sep15 mRNA expression was confi rmed by Northern blot-
ting using a Sep15-specifi c probe. To ensure equal loading of RNA, 
Northern blots were stripped and re-probed using a glycelaldehyde-3-
phosphate dehydrogenase-specifi c probe. Protein expression was as-
sayed by Western blotting using Sep15-specifi c antibodies. Cells sta-
bly transfected with S4-siRNA were used to assess the sensitivity to 
oxidative stress. 
The coding region of the mouse Sep15 gene was PCR-ampli-
fi ed from a cDNA clone with the following primers: 5’-CATTAG-
TATCTAATCTCGAGGGCAGACCGCAGGGAT-3’ and 5’-CTC-
GAGGGATACTCTAGAGCG-3’. The PCR product was digested 
with XhoI/NotI and ligated into the pCI-neo vector (designated 
Sep15/pCI-neo). Mutagenesis of the mouse Sep15 gene was car-
ried out using the QuikChange site-directed mutagenesis kit (Strat-
agene). The following mutagenic primers were used to replace the 
selenocysteine residue: 5’-CTTGAAGTCTGCGGATGTAAATT-
GGGGAGGTTCC-3’ and 5’-GGAACCTCCCCAATTTACATCC-
GCAGACTTCAAG-3’. Expected sequence changes were verifi ed 
by DNA sequencing (designated Sep15-U93C/pCI-neo). NIH-3T3 
cells were transfected with these plasmids as described above. Stable 
transfectants were isolated by resistance to G418. 
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The sensitivity of NIH-3T3 cells to oxidative stress was analyzed 
with the CellTiter 96 AQueous One Solution Cell Proliferation
 Assay 
(Promega). 5 × 103 of cells were seeded into each well of 96-well 
plates and grown overnight in Dulbecco’s modifi ed Eagle’s medium 
supplemented with 10% fetal calf serum. Cells were washed twice 
with phosphate-buffered saline and incubated in serum/phenol red-
free medium containing tert-butyl hydroperoxide and cumyl hydro-
peroxide for 1 h at 37 °C in a humidifi ed 5% CO2 incubator. 20 μl 
of CellTiter 96 AQueous One Solution
 reagent was added to each well 
and incubated for an additional four hours. The A490 was recorded us-
ing an ELx808 Ultra microplate reader (Bio-Tek Instruments). Cell 
viability is expressed as the percentage of untreated controls. 
Expression Pattern Analysis—Four-month-old male BALB/c 
mice were maintained on a Torula yeast diet (Harland Teklad) sup-
plemented with 0, 0.1, or 0.4 ppm selenium in the form of Na2SeO3 
for 1 month. Tissues were homogenized in CelLytic-M lysis buffer 
(Sigma) containing EDTA-free Complete Protease Inhibitor Tablets 
by sonication and centrifuged at 15,000 × g for 20 min. The expres-
sion patterns of Sep15, glutathione peroxidase 1, and thioredoxin re-
ductase 3 were analyzed by Western blotting using antibodies against 
these proteins. 
Results 
Structure Determination—Although SelM and Sep15 are dis-
tant sequence homologs, they do share regions of signifi cant se-
quence identity. Multiple sequence alignments were used to defi ne 
the boundaries of a putative homologous domain that is shared be-
tween these proteins. Residues 1-23 of mouse SelM and residues 
1-16 of fruit fl y Sep15 form signal sequences that are cleaved dur-
ing protein maturation. The chemical shift dispersion of the 1H,15N 
HSQC spectra of full-length SelM (residues 24-145) and full-length 
Sep15 (residues 17-178) revealed the presence of poorly ordered re-
gions in Sep15. By comparing the 1H,15N HSQC spectra of Sep15 
with different construct boundaries, we determined that the N termi-
nus of Sep15 (residues 17-61) was disordered. The high resolution 
solution NMR structures of mouse SelM-48U→C (residues 25-145) 
and the homologous region of fruit fl y Sep15 (residues 62-178) were 
determined under oxidizing conditions by standard double and triple 
resonance experiments using protein samples uniformly labeled with 
15N or 13C,15N (Table 1). A combination of proton-proton distances, 
dihedral angles, hydrogen bonds, and residual dipolar couplings were 
used in the structural calculations (Figure 1A). 
 Overall Description of the Structure—SelM and Sep15 contain a 
central α/β domain (22% sequence identity) that is composed of three 
α-helices (α1- α3) and a mixed parallel/anti-parallel four-stranded 
β-sheet (β1- β4) (Figure 1, A and B). Conserved residues primarily 
form the internal core of this domain and delineate each of the sec-
ondary structural elements (Figure 2). Structure-based multiple se-
quence alignments illustrate that SelM has a short N-terminal exten-
sion that precedes strand β1 and a fl exible C-terminal extension after 
helix α3. In contrast, Sep15 has an elongated cysteine-rich N-termi-
nal extension before strand β1 and a shorter C-terminal extension af-
ter helix α3 that does not adopt a regular secondary structure. The 
sequence of the N-terminal extension of Sep15 is highly conserved 
among Sep15 homologs and is conversely absent in sequence homo-
logs of SelM (Figure 2). 
Comparing the structures of the redox domains of SelM and 
Sep15 with DaliLite (27) shows an overall root mean square devia-
tion of 1.9 Å when comparing the Cα positions of residues 38-112 
of SelM and residues 73-147 of Sep15 (Supplemental Figure 1A). 
A search of the DALI data base of protein structures (28) identifi ed 
members of the thioredoxin superfamily as the closest structural rel-
atives for these proteins. The highest similarities were obtained for 
subunit B8 from human NADH ubiquinone oxidoreductase complex 
I (29), Anabaena thioredoxin 2 (30), and human thioredoxin (31) 
(Supplemental Tables 1 and 2). 
Proteins involved in the regulation of intracellular redox homeo-
stasis and redox-sensitive protein folding pathways often contain 
thioredoxin-like domains. The classical thioredoxin fold is described 
as a three-layer α/β/α sandwich composed of a mixed fi ve-stranded 
β-sheet and two pairs of α-helices that are found on either side of 
the β-sheet (32) (Supplemental Figure 1B). A recent comprehensive 
structural classifi cation of the thioredoxin-like fold (33) describes 
it as a two-layer α/β sandwich composed of a mixed four-stranded 
β-sheet and a pair of α-helices that are packed against one side of 
TABLE 1. Structural statistics for the twenty lowest energy SelM and Sep 15 structures
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the β-sheet. Although SelM and Sep15 share structural similarities 
with other proteins containing thioredoxin-like domains, these NMR 
structures represent the most basic thioredoxin-like fold, contain-
ing only the core secondary structure elements as defi ned by Qi and 
Grishin (33). 
 Sequence and structural motifs can be used to assign which fam-
ily within the thioredoxin superfamily putative thiol-disulfi de oxidore-
ductases may belong (33); however, such comparisons do not provide 
direct evidence of biological function. Using the structural consensus 
of thioredoxin homologs and circular permutations of this fold (33), 
all structurally defi ned proteins containing thioredoxin-like domains 
have been grouped into eleven evolutionary families based on se-
quence, structural, and functional evidence. A manual structure-based 
alignment of SelM and Sep15 demonstrates that they are clearly mem-
bers of the thioredoxin family; however, they do form a distinct sub-
family within that family. As observed with other proteins with thio-
redoxin-like domains, the unusual active-site redox motifs of SelM 
(CGGU) and Sep15 (CGU) are located between the C terminus of 
strand β1 and the N terminus of helix α1 (Figure 1B). The fold and 
location of these redox motifs suggest redox activity for Sep15 and 
FIGURE 1. Solution NMR structures of SelM and 
Sep15. A, backbone superposition of the 20 lowest 
energy structures of SelM (left panel) and Sep15 
(right panel). B, ribbon representation of the SelM 
(left panel) and Sep15 (right panel) structures that 
are closest to the mean with α-helices colored blue 
(α1-α3), β-strands colored orange (β1- β4), and 
coils colored gray. The locations of the redox-active 
motifs for SelM (CXXU) and Sep15 (CXU) are indi-
cated. Residues 25-34 and residues 121-145 (in-
cluding an uncleaved C-terminal hexahistidine tag) 
of SelM are not shown because these regions are 
fl exible. Residues 62-70 (including an uncleaved N-
terminal hexahistidine tag) and residues 150-178 of 
Sep15 are not shown because these regions are 
also fl exible. This fi gure was prepared with MOL-
MOL and PyMOL (52).
FIGURE 2. Structure-based multiple sequence alignment of SelM and Sep15 homologs. Assigned secondary structure elements for SelM 
and Sep15 are indicated above each sequence with α-helices colored blue and β-strands colored orange. Strictly conserved residues are shown 
in blue, and moderately conserved residues are shown in red. The active-site redox motif, including the selenocysteine residue (U), is colored 
green and is located between the C terminus of strand β1 and the N terminus of helix α1. The following accession numbers were used to gen-
erate this alignment: human SelM (27805722); mouse SelM (23956246); zebrafi sh SelM (29648551); human Sep15 (6094261); mouse Sep15 
(20140242); zebrafi sh Sep15 (68053306); rat Sep15 (20139870); mosquito (18389881); fruit fl y Sep15 (24666045). This alignment was produced 
with 3D-COFFEE (53).
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SelM. However, the consensus sequences of the active-site motifs of 
thioredoxins (CGPC), protein disulfi de isomerases (CGHC) and disul-
fi de oxidases (CPHC) are different from those of SelM (CGGC) and 
Sep15 (CG/TC) (4, 33). Many structurally defi ned members of the 
thioredoxin superfamily have a conserved cis-proline residue placed 
near the N terminus of strand β3 (33). Although SelM and Sep15 do 
indeed have prolines located at these positions, they are in the trans-
conformation. However, a charge pair that is involved in the proton 
transfer reaction in thioredoxin (4, 34) and protein disulfi de isomerase 
(4, 35) is not found in SelM and Sep15. Nevertheless, given the simi-
larities to other characterized thiol-disulfi de oxidoreductases (32, 33), 
the surface accessibility and unusual composition of the active-site re-
dox motif, the presence of residues known to infl uence the activity of 
other redox proteins suggests that SelM and Sep15 are thiol-disulfi de 
oxidoreductases that are capable of forming reversible mixed selene-
nylsulfi de bonds during the catalytic cycle of oxidation and reduction. 
Structural Effect of Active-site Disulfi de Bond Reduction—The 
chemical shift dispersion of the 1H,15N HSQC spectra for the oxi-
dized and reduced forms of SelM (Figure 3A) and Sep15 (Figure 3B) 
indicates that they remain folded in both oxidation states. Comparing 
the oxidized and reduced 1H, 15N HSQC spectra demonstrates that 
most of the backbone amide resonances are unchanged by the reduc-
tion of the active-site disulfi de bond and that thiol-disulfi de exchange 
is not accompanied by a large conformational change. However, sig-
nifi cant changes in backbone amide resonances were observed for 
some residues. These differences are consistent with a localized struc-
tural rearrangement centered on the active-site redox motifs of SelM 
(Figure 3A) and Sep15 (Figure 3B). Comparison of the oxidized and 
reduced forms of thioredoxin also shows similar changes surround-
ing the active-site redox motif (36). 
FIGURE 3.  Identifi cation of residues effected by thiol-disulfi de exchange in SelM and Sep15. A, 1H,15N HSQC spectra of SelM. B, Sep15 
without (black) and with (red) 2 mM dithiothreitol (top panel). Amide protons of those residues experiencing minimum chemical shift changes (54) 
(Δδ = ([Δδ1H]2 + 0.1 × [Δδ15N]2)1/2) of one S.D. above the mean (SelM Δδ > 0.11 ppm and Sep15 Δδ > 0.12 ppm) are shown as red spheres (bottom 
panel). Yellow spheres indicate the location of the cysteine and selenocysteine residues that compose the active-site redox motif.
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Redox Potential—As thiol-disulfi de oxidoreductases, SelM and 
Sep15 are potentially involved in the formation, reduction, or isomer-
ization of disulfi de bonds. The propensity of these proteins to donate 
or accept electrons can be expressed as an equilibrium redox potential. 
Biological roles for thiol-disulfi de oxidoreductases can be inferred by 
comparing relative redox potentials. Because preparation of seleno-
proteins in large quantities is diffi cult and a selenocysteine-free ortho-
log of SelM could not be identifi ed in higher eukaryotes, its equilib-
rium redox potential was not determined. However, using the Nernst 
equation, the redox potential of fruit fl y Sep15 (residues 62-178) was 
calculated and found to be –225 mV (Figure 4). The redox potentials 
of selenocysteine-containing Sep15 proteins might differ from that 
of the cysteine-containing fruit fl y Sep15 but should be close to it to 
maintain the function. The calculated redox potential of fruit fl y Sep15 
is higher than that of the strong disulfi de reductant thioredoxin (-270 
mV (37, 38)) and is lower than that of the disulfi de oxidase DsbA (-
122 mV (39, 40)). The redox potential of Sep15 is between that of 
thioredoxin and protein disulfi de isomerase (-175 mV (37)), suggest-
ing that Sep15 may plausibly catalyze the reduction and/or isomeri-
zation of disulfi de bonds in secreted proteins (4). However, the bio-
logical activities of redox proteins within the endoplasmic reticulum 
lumen are infl uenced by protein-protein interactions with other resi-
dent redox proteins, thiol-containing molecules, such as glutathione, 
and molecular oxygen (39). Thus, there may be discrepancies between 
the in vitro and in vivo redox potentials of Sep15. 
Regulation of Sep15 Expression and Oxidative Stress—RNA in-
terference was used to suppress Sep15 gene expression. NIH-3T3 cells 
were transfected with constructs expressing siRNA targeted against 
different regions of mouse Sep15 mRNA (Figure 5A, S1-S4). Northern 
blots demonstrate that the expression of Sep15 mRNA was reduced 
to less than 10% that of wild-type levels for two of the four siRNAs 
tested (Figure 5A). Western blots confi rmed the decrease in Sep15 pro-
tein expression for S4-siRNA (Figure 5B). Depletion of Sep15 mRNA 
by RNA interference increased the viability of these cells to treatment 
with tert-butyl hydroperoxide and cumyl hydroperoxide (Figure 5, C 
and D). To determine whether overexpression of Sep15 might protect 
cells against oxidative stress, stable cell lines that overexpress wild-
type mouse Sep15 or Sep15-U93C were developed (Figure 6A). Cell 
viability assays indicate that overexpression of Sep15 or Sep15-U93C 
also results in increased susceptibility to oxidative stress (Figure 6, B 
and C). These data reveal that altered Sep15 expression disrupts the 
redox homeostasis of the endoplasmic reticulum. 
FIGURE 4.  Determination of the equilibrium redox potential of 
Sep15. 10-μg aliquots of Sep15 (residues 62-178) were equilibrated 
in buffers containing defi ned ratios of reduced-to-oxidized glutathione 
(-240 mV (10 mM GSH/0.1 mM GSSG), -235 mV (10 mM GSH/0.15 
mM GSSG), -231 mV (10 mM GSH/0.2 mM GSSG), -226 mV (10 mM 
GSH/0.3 mM GSSG), -222 mV (10 mM GSH/0.4 mM GSSG), -217 mV 
(10 mM GSH/0.6 mM GSSG), -210 mV (10 mM GSH/1 mM GSSG), -
205 mV (10 mM GSH/1.5 mM GSSG), and -199 mV (10 mM GSH/2.5 
mM GSSG)]) or treated with β-mercaptoethanol (β-ME) before the 
addition of the thiol-alkylating agent 4-acetamido-4’-maleimidylstil-
bene-2,2’-disulfonic acid as a control. Alkylation of reduced cysteine 
residues leads to an increase in molecular mass and altered elec-
trophoretic mobility. These samples were resolved by reducing SDS-
PAGE and analyzed by Western blotting using Sep15-specifi c antibod-
ies. Using the Nernst equation (26), the equilibrium redox potential of 
Sep15 was calculated to be -225 mV.
FIGURE 5.  Viability of Sep15 RNAi knockdown cells to oxidative 
stress. A, Northern blot of Sep15 mRNA levels in NIH-3T3 cells sta-
bly transfected with constructs expressing siRNA targeted against dif-
ferent regions of Sep15 mRNA (S1-S4). Expression of Sep15 mRNA 
is down-regulated by S1, S3, and S4 (top panel). Glycelaldehyde-3-
phosphate dehydrogenase (GAPDH) and ribosomal RNA (28 S and 
18 S) controls are shown in the middle and lower panels, respectively. 
kb, kilobases. B, Western blot of Sep15 protein expression. C, viability 
of cells to tert-butyl hydroperoxide (t-BOOH) treatment. D, viability of 
cells to cumyl hydroperoxide treatment. Results are presented as the 
mean ± S.D. of four replicate experiments.
FIGURE 6.  Viability of cells overexpressing Sep15 or Sep15-U93C 
to oxidative stress. A, Western blot of Sep15 protein expression (left 
panel) and naphthol blue-black staining of the control gel (right panel). 
B, viability of cells overexpressing Sep15 or Sep15-U93C to tert-butyl 
hydroperoxide (t-BOOH) treatment. C, viability of cells overexpressing 
Sep15 or Sep15-U93C to cumyl hydroperoxide treatment. Results are 
presented as the mean ± S.D. of four replicate experiments.
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Regulation of Sep15 Expression by Dietary Selenium—The dif-
ferential expression of Sep15 in response to selenium availability 
was assayed. Mice maintained on a Torula yeast diet supplemented 
with 0, 0.1, or 0.4 ppm selenium was sacrifi ced after 1 month of di-
etary selenium supplementation. Western blotting was used to deter-
mine the expression patterns of Sep15, glutathione peroxidase 1 and 
thioredoxin reductase 3 (Figure 7). Sep15 expression was reduced in 
the liver and kidneys of mice maintained on a selenium-defi cient diet 
as compared with those maintained with 0.1 and 0.4 ppm selenium. 
In contrast, Sep15 expression in the testes was less responsive to se-
lenium defi ciency. We were unable to detect glutathione peroxidase 
1 expression under selenium-defi cient conditions in these tissues. As 
observed with Sep15, the expression pattern of thioredoxin reductase 
3 was less responsive to the availability of selenium. These data are 
consistent with previous studies showing that the expression patterns 
of selenoproteins localized to the liver and kidneys are highly respon-
sive to the availability of selenium and that the testes retain the ma-
jority of selenium under selenium-defi cient conditions (41, 42). The 
underlying mechanism for this asymmetric distribution of selenium 
is unknown. 
Discussion 
Thiol-disulfi de oxidoreductases (including thioredoxins, protein 
disulfi de isomerases, and disulfi de oxidases) catalyze the correct for-
mation of disulfi de bonds. Although a growing number of eukaryotic 
protein disulfi de isomerases have been identifi ed in the endoplasmic 
reticulum (4), biological activities for most of these proteins remain 
unknown. Protein disulfi de isomerases typically consist of two cat-
alytic thioredoxin-like domains (a and a’) that each contain an ac-
tive-site redox motif which are separated by two non-catalytic thio-
redoxin-like domains (b and b’). However, some protein disulfi de 
isomerases, such as ERp18 (43) and ERp44 (44), only possess a sin-
gle catalytic a-domain. By analogy to human protein disulfi de isom-
erase, SelM and Sep15 are composed of one catalytic a-domain that 
assumes a thioredoxin-like fold composed of a mixed four-stranded 
β-sheet and three interspersed α-helices. The secondary structure ele-
ments that form this thioredoxin-like domain appear to be highly con-
served among SelM and Sep15 homologs. Although members of the 
thioredoxin superfamily were identifi ed as the closest structural rela-
tives for SelM and Sep15, sequence and structural comparisons dem-
onstrate that they form a distinct evolutionary family. As observed 
in thioredoxin (32, 36) and the a-domain of human protein disulfi de 
isomerase (45), the active-site redox motifs of SelM and Sep15 are 
located between the C terminus of strand β1 and the N terminus of 
helix α1. In contrast to thioredoxin, both active-site redox residues 
(cysteine or selenocysteine) are surface-accessible, as found in the a-
domain of protein disulfi de isomerase. The unusual selenocysteine-
containing redox motifs of SelM and Sep15 are capable of forming 
reversible mixed selenenylsulfi de bonds during the catalytic cycle 
of oxidation and reduction. Reduction of the active-site disulfi de (or 
selenenylsulfi de) bond results in localized conformational changes 
that are centered on the redox motif. The calculated redox potential 
of fruit fl y Sep15 (–225 mV) lies in between that of thioredoxin and 
protein disulfi de isomerase, suggesting that Sep15 may catalyze the 
reduction and/or isomerization of disulfi de bonds by functioning as 
a weak reductant or protein disulfi de isomerase. Although the intro-
duction of a selenocysteine residue into the active-site redox motif 
would lower the equilibrium redox potential, there may be compen-
satory sequence changes that may equalize the redox potentials of 
cysteine and selenocysteine-containing orthologs. 
The non-catalytic b’-domain of human protein disulfi de isomer-
ase functions as the primary binding site for peptide and protein sub-
strates. The highly fl exible C-terminal extensions of SelM (residues 
121-145) and Sep15 (residues 150-178) may perform an analogous 
role and assume a defi ned conformation after the binding of protein 
substrates or other redox proteins. The N-terminal extension of SelM 
(residues 25-34) is relatively short, whereas the equivalent region of 
Sep15 (residues 17-61) forms a distinct cysteine-rich domain. A short 
linker (residues 62-70) connects the N- and C-terminal domains of 
Sep15. The cysteine-rich domain of Sep15 has an established func-
tion; it mediates the formation of a high affi nity 1:1 complex (appar-
ent KD of 20 nM) between
 Sep15 and the folding sensor of the cal-
nexin cycle-UDP-glucose:glycoprotein glucosyltransferase (UGGT) 
(46, 47). SelM and its homologs do not contain an equivalent region 
and, accordingly, do not form complexes with UGGT (46). 
The calnexin cycle is an essential quality control pathway lo-
calized to the endoplasmic reticulum that assists in the folding of 
N-linked glycoproteins. Selenoproteins have not previously been 
shown to be involved in the quality control pathways of the endo-
plasmic reticulum. However, the observation that Sep15 co-puri-
fi es with UGGT indicates that this selenoprotein may be indirectly 
involved in the calnexin cycle by likely functioning as a protein 
disulfi de isomerase co-factor that assists UGGT in assessing the 
structural fi delity of misfolded glycoproteins. Alternatively, UGGT 
may have a role of a primary binding site for Sep15 substrates, 
analogous to the non-catalytic b’-domain of human protein disul-
fi de isomerase. 
In contrast to protein disulfi de isomerase and its broad substrate 
specifi city, SelM and Sep15 may service a restricted group of protein 
substrates as demonstrated for protein disulfi de isomerase ERp57 (a 
member of the calnexin cycle), which functions exclusively as an 
isomerase for partially folded glycoproteins that are bound to the 
chaperones calnexin and calreticulin (48–50). Large multiprotein 
complexes that are composed of various chaperones form networks 
within the lumen of the endoplasmic reticulum (51). These pre-
formed complexes concentrate multiple chaperones and other fold-
ing enzymes upon newly synthesized proteins and prevent partially 
folded proteins from prematurely progressing through the secretory 
pathway. The association of Sep15 with UGGT directly links this 
selenoprotein to these networks. The biochemical and structural data 
presented here suggest that unusual active-site redox motif of Sep15 
may participate in the reduction or isomerization of disulfi de bonds 
of glycoprotein substrates of UGGT. 
Collectively, the identifi cation of a thioredoxin-like domain and 
the presence of a surface-accessible active-site redox motif, sequence, 
and structural similarities to other characterized thiol-disulfi de oxido-
reductases and the determination of the redox potential of Sep15 sug-
gest that SelM and Sep15 are thiol-disulfi de isomerases that are in-
volved in disulfi de bond formation in the endoplasmic reticulum. 
FIGURE 7.  Regulation of Sep15 expression by dietary selenium. 
Tissue extracts from mice maintained on diets containing 0, 0.1, or 0.4 
ppm dietary selenium were resolved by SDS-PAGE and analyzed by 
Western blotting with antibodies specifi c for Sep15 (top panel), gluta-
thione peroxidase 1 (GPx1) (middle panel), and thioredoxin reductase 
3 (TR3) (bottom panel).
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SUPPLEMENTAL TABLE ONE. DALI comparisons using the structure of the redox 
domain of SelM that is closest to the mean of the ensemble 
 
PDB Z-score Sequence Identity Protein 
2a4h 9.9 22% Fruit fly Sep15 
1s3a 7.4 14% Subunit B8 from human NADH ubiquinone 
oxidoreductase complex I 
1thx 5.4 12% Anabaena thioredoxin 2 
1b9y 4.9 6% Bull transducin βγ fragment 
1erv 4.7 10% Human thioredoxin mutant 
1a8y 4.7 5% Rabbit calsequestrin 
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SUPPLEMENTAL TABLE TWO. DALI comparisons using the structure of the redox 
domain of Sep15 that is closest to the mean of the ensemble 
 
PDB Z-score Sequence Identity Protein 
2a2p 9.9 22% Mouse SelM 
1s3a 6.1 16% Subunit B8 from human NADH ubiquinone 
oxidoreductase complex I 
1erv 4.8 11% Human thioredoxin mutant 
1xvw 4.6 8% Mycobacterium tuberculosis AhpE 
1thx 4.2 10% Anabaena thioredoxin 2 
1a8y 4.2 9% Rabbit calsequestrin 
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SUPPLEMENTAL FIGURE 1. Stereoviews of structural comparisons. A, Backbone 
superposition of SelM (magenta) and Sep15 (yellow). B, Backbone superposition of SelM 
(magenta) and human thioredoxin (yellow). 
 
